Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio (Q92757923)
Jump to navigation
Jump to search
scientific article published on 19 May 2019
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio |
scientific article published on 19 May 2019 |
Statements
Optimal adjuvant therapy in clinically N2 non-small cell lung cancer patients undergoing neoadjuvant chemotherapy and surgery: The importance of pathological response and lymph node ratio (English)
Erminia Massarelli
Ashwin Shinde
Zachary D Horne
Richard Li
Scott Glaser
Marianna Koczywas
Loretta Erhunmwunsee
Karen L Reckamp
Ravi Salgia
Sushil Beriwal